Tracking Virginia’s General Assembly
since 2007.
HB1092: Income tax, corporate; biotechnology investment tax credit.
Chief Patron
Del.
Mark Sickles (D-43)
Mark Sickles
(D-43)
Alexandria, VA
Served: 2004–
Progress
| Introduced | |
| Passed Committee | |
| Passed House | |
| Passed Senate | |
| Signed by Governor | |
| Became Law |
Status
01/15/2008: In Finance Committee
Summary
Virginia Biotechnology Investment Tax Credit. Creates a research and development tax credit, not to exceed 50 percent of the tax liability due and not to exceed $500,000, for biotechnology companies in Virginia and permits the credit to be carried over for up to 10 years, for taxable years beginning on and after January 1, 2008. This tax credit, not to exceed 15 percent of the qualified investment, can be claimed for each of the five tax years beginning on and after January 1, 2008. In no event will more than $5 million in either of the credits be allowed annually.
View Full Text »Video
Votes were cast on this bill on the following dates for which Richmond Sunlight has video: 01/09/2008, 01/09/2008, 01/24/2008, 01/24/2008, 02/04/2008 and 02/04/2008.
Poll Results
2 votes

Comments
Supporting biotechnology will bring in an innovative new industry to Virginia and create high paying jobs.